RETRACTION: Silencing EGFR/HER3 signaling with a novel anti-EGFR domain II/IV antibody (Retraction of Vol 357, Pg 374, 2015)CANCER LETTERSIF10.12017-08-011PREAI
Structure-based development and optimization of therapy antibody drugs against TNFα (Retraction of vol 47, pg 1259, 2015)AMINO ACIDSIF2.42015-12-091OA
RETRACTED: Structure-based development and optimization of therapy antibody drugs against TNFα (Retracted article. See vol. 48, pg. 319, 2016)AMINO ACIDSIF2.42015-03-141PREAI
RETRACTED: Silencing EGFR/HER3 signaling with a novel anti-EGFR domain II/IV antibody(Retracted article.See vol.401, pg.81, 2017)CANCER LETTERSIF10.12015-02-013PREAI
Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodiesMABSIF7.32014-04-1638OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项